Renaissance Technologies’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.44M	Sell	1,620,100 -574,500	-26%	-$1.82M	0.01%	1444
2025 Q4	$8.12M	Buy	2,194,600 +1,420,700	+184%	+$4.59M	0.01%	1028
2025 Q3	$2.05M	Buy	773,900 +481,500	+165%	+$931K	﹤0.01%	2054
2025 Q2	$288K	Buy	+292,400	New	+$293K	﹤0.01%	3056
2025 Q1	–	Sell	-578,800	Closed	-$1.27M	–	3560
2024 Q4	$1.27M	Sell	578,800 -335,300	-37%	-$782K	﹤0.01%	2345
2024 Q3	$1.51M	Sell	914,100 -507,800	-36%	-$1.03M	﹤0.01%	2198
2024 Q2	$3.16M	Sell	1,421,900 -694,600	-33%	-$1.63M	0.01%	1586
2024 Q1	$5.67M	Buy	2,116,500 +696,400	+49%	+$1.69M	0.01%	1338
2023 Q4	$4.25M	Buy	1,420,100 +1,213,944	+589%	+$1.57M	0.01%	1454
2023 Q3	$202K	Buy	206,156 +91,856	+80%	+$133K	﹤0.01%	3090
2023 Q2	$159K	Buy	+114,300	New	+$160K	﹤0.01%	3341
2022 Q4	–	Sell	-286,700	Closed	-$1.92M	–	4183
2022 Q3	$1.92M	Sell	286,700 -98,600	-26%	-$677K	﹤0.01%	2042
2022 Q2	$2.45M	Sell	385,300 -36,900	-9%	-$209K	﹤0.01%	2039
2022 Q1	$1.96M	Buy	+422,200	New	+$1.81M	﹤0.01%	2245
2019 Q4	–	Sell	-141,900	Closed	-$5.2M	–	3558
2019 Q3	$5.2M	Sell	141,900 -95,600	-40%	-$3.79M	﹤0.01%	1770
2019 Q2	$11M	Buy	237,500 +41,905	+21%	+$1.97M	0.01%	1334
2019 Q1	$7.85M	Buy	195,595 +177,695	+993%	+$7.97M	0.01%	1512
2018 Q4	$823K	Buy	+17,900	New	+$862K	﹤0.01%	2668
2017 Q4	–	Sell	-14,500	Closed	-$727K	–	3378
2017 Q3	$727K	Buy	+14,500	New	+$699K	﹤0.01%	2685
2016 Q4	–	Sell	-318,800	Closed	-$4.42M	–	3297
2016 Q3	$4.42M	Buy	+318,800	New	+$3.61M	0.01%	1683
2016 Q2	–	Sell	-107,600	Closed	-$1.82M	–	3374
2016 Q1	$1.82M	Sell	107,600 -253,600	-70%	-$4.08M	﹤0.01%	2279
2015 Q4	$8.04M	Buy	+361,200	New	+$9.11M	0.02%	1140